Free Thyroxine During Early Pregnancy and Risk for Gestational Diabetes

Area of Science:

• Endocrinology
• Maternal-Fetal Medicine
• Metabolic Disorders

Background:

• Gestational diabetes mellitus (GDM) is a growing concern in pregnancy.
• Previous studies suggest an association between low free thyroxine (fT4) and GDM, particularly in later pregnancy stages.
• The role of thyroid hormones in GDM causality requires further investigation.

Purpose of the Study:

• To examine the relationship between maternal weight, free thyroxine (fT4) levels, and gestational diabetes mellitus (GDM).
• To determine if low fT4 contributes to the causality of GDM.
• To analyze thyroid hormone levels in relation to GDM risk during different trimesters of pregnancy.

Main Methods:

• Analysis of data from 9351 euthyroid women in the First and Second Trimester Evaluation of Risk (FaSTER) trial.
• Measurement of thyrotropin (TSH), fT4, and thyroid antibodies in the first and second trimesters.
• Statistical analysis to assess associations between fT4, maternal weight, age, and GDM status.

Main Results:

• Women with GDM were older and weighed more than those without GDM.
• Second-trimester low fT4 was significantly associated with a higher risk of GDM (adjusted OR 1.89).
• First-trimester fT4 levels did not show a significant association with GDM risk.

Conclusions:

• Maternal weight is associated with both lower fT4 and increased GDM risk in the second trimester.
• Low second-trimester fT4 may serve as a marker for increased peripheral deiodinase activity, potentially contributing to GDM.
• Thyroid hormone status, particularly fT4 in the second trimester, warrants attention in the context of GDM development.